Hematologic complications from tranquilizers in children.
D000293:Adolescent; D000367:Age Factors; D000380:Agranulocytosis / Q000139:chemically induced; D001856:Bone Marrow Examination; D001925:Brain Damage, Chronic / Q000188:drug therapy; D001927:Brain Diseases / Q000188:drug therapy; D002648:Child; D003913:Dextroamphetamine / Q000009:adverse effects; D004802:Eosinophilia / Q000139:chemically induced*; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects; D006801:Humans; D007099:Imipramine / Q000009:adverse effects; D007958:Leukocyte Count; D007964:Leukocytosis / Q000139:chemically induced*; D007970:Leukopenia / Q000139:chemically induced*; D008297:Male; D008774:Methylphenidate / Q000009:adverse effects; D010634:Phenobarbital / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D012737:Sex Factors; D013881:Thioridazine / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects
D014149:Tranquilizing Agents; D008774:Methylphenidate; D010672:Phenytoin; D013881:Thioridazine; D007099:Imipramine; D005476:Fluphenazine; D003913:Dextroamphetamine; D010634:Phenobarbital